CARDIAC-HYPERTROPHY PROCESS - ANALYSES OF FACTORS DETERMINING PATHOLOGICAL VS PHYSIOLOGICAL DEVELOPMENT

被引:261
作者
WIKMANCOFFELT, J
PARMLEY, WW
MASON, DT
机构
[1] UNIV CALIF SAN FRANCISCO, SCH MED,CARDIOVASC MED SECT, SAN FRANCISCO, CA 94143 USA
[2] UNIV CALIF DAVIS, SCH MED, DAVIS, CA 95616 USA
[3] UNIV CALIF SAN FRANCISCO, SCH MED,PHYSIOL SECT, SAN FRANCISCO, CA 94143 USA
关键词
D O I
10.1161/01.RES.45.6.697
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This review has been concerned with a general review of the hypertrophy process and its evolution into either physiological or pathological hypertrophy. The constellation of factors which determine the course of the hypertrophy process are essentially a combination of four major determinants; the degree of ventricular wall stress, the duration of such stress, and the nature of the inciting stimulus, as well as the species, age, and health of the animal. The indices, myosin ATPase activity and velocity of muscle shortening, used to distinguish the two types of hypertrophy, have been studied more extensively than other criteria at this time. Future studies may, however, reveal new parameters which will further correlate with the known data, making it easier to understand the evolution of physiological vs. pathological hypertrophy. The evolution of hypertrophy, the parameters affecting its development into either physiological or pathological hypertrophy, and the indices used to distinguish the two types of hypertrophy are presented in this review as initial developments in unification of this complicated subject.
引用
收藏
页码:697 / 707
页数:11
相关论文
共 117 条
  • [41] DISSOCIATION OF LIGHT-CHAINS FROM CARDIAC MYOSIN
    HIGUCHI, M
    FABIAN, F
    WANDZILAK, T
    MASON, DT
    WIKMANCOFFELT, J
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1978, 92 (02): : 317 - 323
  • [42] IMMUNOLOGICAL, ELECTROPHORETIC AND KINETIC-PROPERTIES OF CARDIAC MYOSINS FROM VARIOUS SPECIES
    HIGUCHI, M
    STEWART, D
    MASON, DT
    IKEDA, R
    WIKMANCOFFELT, J
    [J]. COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 1978, 60 (04): : 495 - 499
  • [43] HONIG CR, 1974, CIRC RES, V35, P97
  • [44] KOMPMANN M, 1966, ARCH PATHOL, V82, P303
  • [45] Korecky B, 1974, Recent Adv Stud Cardiac Struct Metab, V4, P77
  • [46] KORECKY B, 1978, AM J PHYSIOL-HEART C, V3, P123
  • [47] KOSSMAN E, 1965, DISEASES HEART BLOOD, P52
  • [48] AUGMENTED SYMPATHETIC NEUROTRANSMITTER ACTIVITY IN PERIPHERAL VASCULAR BED OF PATIENTS WITH CONGESTIVE HEART FAILURE AND CARDIAC NOREPINEPHRINE DEPLETION
    KRAMER, RS
    MASON, DT
    BRAUNWALD, E
    [J]. CIRCULATION, 1968, 38 (04) : 629 - +
  • [49] NOREPINEPHRINE - PRODUCER OF MYOCARDIAL CELLULAR HYPERTROPHY AND-OR NECROSIS AND-OR FIBROSIS
    LAKS, MM
    [J]. AMERICAN HEART JOURNAL, 1977, 94 (03) : 394 - 394
  • [50] CANINE RIGHT AND LEFT VENTRICULAR CELL AND SARCOMERE LENGTHS AFTER BANDING PULMONARY ARTERY
    LAKS, MM
    MORADY, F
    SWAN, HJC
    [J]. CIRCULATION RESEARCH, 1969, 24 (05) : 705 - +